A combined rapid diagnostic test for simultaneous detection of COVID-19 and influenza A&B pathogens. FDA 510(k) cleared and Health Canada approved for home use.
Manufactured by
United States
Wondfo USA is a branch of Wondfo Biotech Co., Ltd. located in the United States. Wondfo USA distributes rapid drug testing kits as well as other POCT products, which are manufactured by its parent company. Headquartered in Guangzhou, China, Wondfo is a globally recognized fast-growing POCT manufacturer specialized in R&D, manufacture, and sales of rapid diagnostic tests and related medical devices for in vitro diagnostics.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Boston Easy Biotech Inc.
United States · 2 relevant products
ACON Laboratories, Inc.
United States · 2 relevant products
Xiamen Biotime Biotechnology Co., Ltd.
China · 2 relevant products
Access Bio, Inc.
United States · 2 relevant products
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 6 relevant products
Beijing Jinwofu Bioengineering Technology Co.,Ltd.
China · 4 relevant products
Hangzhou Fanttest Biotech Co., Ltd.
China · 3 relevant products
ProGnosis Biotech S.A.
Greece · 3 relevant products
Advin Biotech, Inc.
United States · 1 relevant product
Hecin Scientific, Inc.
China · 3 relevant products
60 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 113 closest product alternatives
Boston Easy Biotech Inc. · United States
FDA-cleared rapid diagnostic test for simultaneous detection of Influenza A and B antigens. Provides fast, reliable results in clinical and point-of-care settings. Designed for ease of use and quick turnaround in respiratory infection screening.
ACON Laboratories, Inc. · United States
A multiplex lateral flow immunoassay for simultaneous detection of SARS-CoV-2, influenza A, and influenza B. FDA-cleared for home-based testing with extended shelf-life stability.
Xiamen Biotime Biotechnology Co., Ltd. · China
Multiplex rapid diagnostic test for simultaneous detection of SARS-CoV-2 antigen and influenza A/B viruses.
Access Bio, Inc. · United States
Multiplexed rapid antigen home test detecting COVID-19, Influenza A, and Influenza B simultaneously. Single test for differentiation of common respiratory pathogens.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
Multiplex lateral flow assay for simultaneous detection of COVID-19 and influenza A and B antigens. Allows differentiation of respiratory pathogens in a single test.
Beijing Jinwofu Bioengineering Technology Co.,Ltd. · China
A rapid antigen test kit for simultaneous detection of Influenza A, Influenza B, and COVID-19 (SARS-CoV-2). This combo test enables efficient screening for multiple respiratory viruses in a single procedure.
Hangzhou Fanttest Biotech Co., Ltd. · China
A multiplex antigen test kit designed to detect COVID-19, Influenza A, and Influenza B in a single test. The kit provides rapid results for differentiation between these common respiratory infections.
ProGnosis Biotech S.A. · Greece
Rapid lateral flow test kit for simultaneous Influenza A and B detection. Validated diagnostic tool certified to ISO 13485:2016 medical device standards.
Advin Biotech, Inc. · United States
Multiplex rapid test simultaneously detecting COVID-19, influenza A, and influenza B from a single specimen. FDA cleared with results available in 5 minutes.
Hecin Scientific, Inc. · China
A multiplex diagnostic test kit for rapid simultaneous detection of SARS-CoV-2, influenza A, and influenza B antigens. This immunochromatographic test provides comprehensive respiratory pathogen screening for clinical diagnosis.
ProGnosis Biotech S.A. · Greece
Rapid antigen test for simultaneous detection of influenza A & B and COVID-19 using advanced antigen-antibody technology. Delivers fast, reliable results for respiratory infection screening in clinical settings. ELISA and lateral flow formats available for point-of-care and laboratory use.
SureScreen Diagnostics Limited · United Kingdom
A rapid diagnostic test that delivers simultaneous results for both COVID-19 and influenza viruses, helping clinicians make informed decisions and patients receive appropriate care quickly.
101 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products